BackCYduct Diagnostics Overview
CYduct Diagnostics, Inc.

CYduct Diagnostics Return on Equity

CYduct Diagnostics (CYDX) has a ROE of 13.05%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

13.05%

Return on Equity

13.05%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

CYduct Diagnostics (CYDX) FAQ

The latest ROE for CYDX is 13.05%. That is above the sector sector average of 11.3%. Investors often review this figure alongside CYduct Diagnostics's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CYDX currently prints 13.05% for ROE, while the sector average sits near 11.3%. That is roughly 15.5% above the sector mean. Large gaps often invite a closer look at CYduct Diagnostics's growth, margins, and balance sheet.

Return on Equity shows how effectively CYduct Diagnostics converts resources into returns. At 13.05%, CYDX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CYDX's ROE (13.05%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers